Skip to main content

Find Clinical Trials

Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

NCT00095108

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Completed

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)

NCT00609401

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: Istituto Tumori Milan, Italy

View Trial Details

Completed

Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas

NCT00152126

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

CPG 7909 in Patients Wih Stage IV Renal Cell Cancer

NCT00043407

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Not specified

View Trial Details

Completed

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00005966

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States

CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States

John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines, Iowa, United States

Mercy Cancer Center at Mercy Medical Center-Des Moines Des Moines, Iowa, United States

View all 14 locations

View Trial Details

Completed

Relationship of Ochratoxin A to Upper Urologic Cancers

NCT00216801

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: St. Josephs Health Care London, Ontario, Canada

View Trial Details

Completed

Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC

NCT00496301

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Hospital Santiago de Compostela A Coruña, Spain

Hospital del Mar Barcelona, Spain

Hospital Vall d´Hebron Barcelona, Spain

Hospital de Basurto Bilbao, Spain

View Trial Details

Completed

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

NCT00336531

Conditions: Bacterial Infections and Mycoses, Brain Diseases, Brain Neoplasms, +38 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

NCT00421512

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, United States

View Trial Details

Completed

Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT

NCT00246974

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Research Site Aachen, Germany

Research Site Augsburg, Germany

Research Site Berlin, Germany

Research Site Dresden, Germany

View all 14 locations

View Trial Details